Stage III Bladder Urothelial Carcinoma

specific

Stage III includes: (T3a, N0, M0); (T3b, N0, M0); (T4a, N0, M0). T3a: Tumor microscopically invades perivesical tissue. T3b: Tumor macroscopically invades perivesical tissue (extravesical mass). T4a: Tumor invades prostatic stroma, uterus, vagina. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)

28

Centers

27

Active Trials

Cancer Funding

Top Centers for Stage III Bladder Urothelial Carcinoma(28)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
52.6
2
NCI Comprehensive
Active Research Program
52.6
3
NCI Comprehensive
Active Research Program
52.6
4
NCI Comprehensive
Active Research Program
52.6
5
NCI Comprehensive
Active Research Program
52.6
6
NCI Comprehensive
Active Research Program
52.6
752.6
8
NCI Comprehensive
Active Research Program
52.6
9
NCI Comprehensive
Active Research Program
52.6
10
NCI Comprehensive
Active Research Program
52.6
11
NCI Clinical
Active Research Program
52.6
12
NCI Comprehensive
Active Research Program
52.6
13
NCI Comprehensive
Active Research Program
52.6
14
NCI Clinical
Active Research Program
52.6
15
NCI Comprehensive
Active Research Program
52.6
16
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
52.6
17
Active Research Program
52.6
18
NCI Clinical
Active Research Program
52.6
19
NCI Comprehensive
Active Research Program
52.6
20
Active Research Program
52.6
21
Active Research Program
52.6
22
Active Research Program
52.6
23
Active Research Program
52.6
24
Active Research Program
52.6
25
Active Research Program
52.6
26
Active Research Program
52.6
27
Active Research Program
52.6
28
NCI Comprehensive
30.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →